News Focus
News Focus
icon url

kgromax

01/09/22 5:49 PM

#199770 RE: moneycrew #199768

The HIV trials magically never led to a proper BLA submission. And the root cause, Nader's deicsion to illegally submit an incomplete BLA if needed, casts a shadow over the entire trial. No sane CEO would have done that.

Cytodyn's success are only hearsay: sentences repeated by illegal promoters to convince retail investors that something is going on. Magically, NONE of that could get written properly in a FDA document (or equivalent: European regulator, UK regulator, etc....) following scientific standards. Like a p-value that has not been hacked, or if it has, that follows standards for multiple testing corrections. These standards have NEVER been followed.

This is not incompetence. This is volontary fraud.

While they were committing fraud, in parallel the CEO and CFO have dumped >85% of their shares on the retail investors. And NEVER, NEVER have they purchased any share on the market. They only converted low-strike warrants.

This company is a fraud. It's so obvious. And the stock price trajectory reflects that perfectly.
icon url

3X Charm

01/09/22 5:59 PM

#199772 RE: moneycrew #199768

Pharma executives will not take an asymmetrical risk on a company with all these failed trials, shenanigans of purposely submitted “short BLA” AND SEC AND DOJ INVESTIGATIONS!

I have personally spoken to Pharma CEOs and senior executives on this very topic. They would much rather pay a premium when success is imminent than waste shareholders equity on a unproven dog.

Unlike Nader, CEOS of other companies are accountable to the BOD and shareholders. Laughing at the nonsense and fairytales.

No way any company of any import takes on CYDY a with its let’s generously say “ huge # of WARTS”.
icon url

theswordman

01/09/22 6:23 PM

#199773 RE: moneycrew #199768

IF ANYONE wanted to believe this--why wouldn't ANY company just buy shares @ under $1--get a control interest--say 51% or so. As the hostile takeover becomes apparent--the price jumps to 2 or $3. Is that a "sick amount"??

Please explain how Vyera selling rights (U S HIV) puts Leronlimab in any "crosshairs"?? Wouldn't CYDY have been much better served to purchase those "rights" and have complete control--especially at the stated price??

We are in Pfizer crosshairs--DON'T BLINK !!!!!!!!
______________________________________________________
I blinked a few months ago--I missed the data on the Phillipines 28 patients we were to receive
Also I blinked and missed the enrollment updates for Brazil
I Blinked and missed the "will put into public domain" the problems with the receptor occupancy testing

EVERY employee @ CYDY blinked--filed a BTD and didn't realize there was a new drug approved almost 2 years ago for a new SOC
Talk about BLINK--the BLA is now 4 years behind schedule
icon url

crazyjogger925

01/09/22 6:31 PM

#199774 RE: moneycrew #199768

pfizer would be wise to scoop up LL since german doctors claim their vaccines contain "astonishing "impurities. plus a judge has ruled pfizer cant slow roll their data release for up to 60-70 years.

https://rairfoundation.com/bombshell-german-doctors-find-astonishing-impurities-in-covid-vaccine-video/